Healthcare services provider BrightSpring Health Services (NASDAQ: BTSG) will be reporting results this Friday morning. Here’s what you need to know.

BrightSpring Health Services beat analysts’ revenue expectations last quarter, reporting revenues of $3.61 billion, up 25.6% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and full-year EBITDA guidance topping analysts’ expectations.

Is BrightSpring Health Services a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting BrightSpring Health Services’s revenue to grow 16.2% year on year, slowing from the 29.1% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. BrightSpring Health Services has missed Wall Street’s revenue estimates multiple times over the last two years.

Looking at BrightSpring Health Services’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Chemed delivered year-on-year revenue growth of 8.8%, beating analysts’ expectations by 1.2%, and Option Care Health reported revenues up 1.9%, topping estimates by 1.6%. Chemed traded up 4.2% following the results.

Read our full analysis of Chemed’s results here and Option Care Health’s results here.

There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 4.9% on average over the last month. BrightSpring Health Services’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $76.29 (compared to the current share price of $69.62).

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.